|
1
|
Azar I, Kumar D and Betcher AM: Resistance
to pancuronium in an asthmatic patient treated with aminophylline
and steroids. Can Anaesth Soc J. 29:280–282. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Laflin MJ: Interaction of pancuronium and
corticosteroids. Anesthesiology. 47:471–472. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyers EF: Partial recovery from
pancuronium neuromuscular blockade following hydrocortisone
administration. Anesthesiology. 46:148–150. 1977. View Article : Google Scholar
|
|
4
|
Soltész S, Mencke T, Stunz M, Diefenbach
C, Ziegeler S and Molter GP: Attenuation of a rocuronium-induced
neuromuscular block in patients receiving prednisolone. Acta
Anaesthesiol Scand. 53:443–448. 2009.PubMed/NCBI
|
|
5
|
Soltész S, Mencke T, Mey C, Röhrig S,
Diefenbach C and Molter GP: Influence of a continuous prednisolone
medication on the time course of neuromuscular block of atracurium
in patients with chronic inflammatory bowel disease. Br J Anaesth.
100:798–802. 2008.
|
|
6
|
Parr SM, Galletly DC and Robinson BJ:
Betamethasone-induced resistance to vecuronium: a potential problem
in neurosurgery? Anaesth Intensive Care. 19:103–105.
1991.PubMed/NCBI
|
|
7
|
Arts WF and Oosterhuis HJ: Effect of
prednisolone on neuromuscular blocking in mice in vivo. Neurology.
25:1088–1090. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Robinson BJ, Lee E, Rees D, Purdie GL and
Galletly DC: Betamethasone-induced resistance to neuromuscular
blockade: a comparison of atracurium and vecuronium in vitro.
Anesth Analg. 74:762–765. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parr SM, Robinson BJ, Rees D and Galletly
DC: Interaction between betamethasone and vecuronium. Br J Anaesth.
67:447–451. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dal Belo CA, Leite GB, Fontana MD, et al:
New evidence for a presynaptic action of prednisolone at
neuromuscular junctions. Muscle Nerve. 26:37–43. 2002.PubMed/NCBI
|
|
11
|
Dalkara T and Onur R: Facilitatory effects
of dexamethasone on neuromuscular transmission. Exp Neurol.
95:116–125. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leeuwin RS, Njio KD, Belling GA and van
den Hoven S: Glucocorticoid-induced changes in synaptic vesicles of
rat phrenic nerve terminals. Arch Int Pharmacodyn Ther.
266:200–207. 1983.PubMed/NCBI
|
|
13
|
Leeuwin RS, Veldsema-Currie RD, van
Wilgenburg H and Ottenhof M: Effects of corticosteroids on
neuromuscular blocking actions of d-tubocurarine. Eur J Pharmacol.
69:165–173. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van Wilgenburg H, Njio KD, Belling GA and
Van den Hoven S: Effects of corticosteroids on the myoneural
junction. A morphometric and electrophysiological study. Eur J
Pharmacol. 84:129–137. 1982.PubMed/NCBI
|
|
15
|
Veldsema-Currie RD, Wolters E and Leeuwin
RS: The effect of corticosteroids and hemicholinium-3 on choline
uptake and incorporation into acetylcholine in rat diaphragm. Eur J
Pharmacol. 35:399–402. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pereira RM and Freire de Carvalho J:
Glucocorticoid-induced myopathy. Joint Bone Spine. 78:41–44. 2011.
View Article : Google Scholar
|
|
17
|
Yamamoto D, Maki T, Herningtyas EH, et al:
Branched-chain amino acids protect against dexamethasone-induced
soleus muscle atrophy in rats. Muscle Nerve. 41:819–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Inder WJ, Jang C, Obeyesekere VR and
Alford FP: Dexamethasone administration inhibits skeletal muscle
expression of the androgen receptor and IGF-1 - implications for
steroid-induced myopathy. Clin Endocrinol (Oxf). 73:126–132.
2010.
|
|
19
|
Schakman O, Gilson H, Kalista S and
Thissen JP: Mechanisms of muscle atrophy induced by
glucocorticoids. Horm Res. 72(Suppl 1): 36–41. 2009. View Article : Google Scholar
|
|
20
|
Schakman O, Gilson H and Thissen JP:
Mechanisms of glucocorticoid-induced myopathy. J Endocrinol.
197:1–10. 2008. View Article : Google Scholar
|
|
21
|
Nava S, Gayan-Ramirez G, Rollier H, et al:
Effects of acute steroid administration on ventilatory and
peripheral muscles in rats. Am J Respir Crit Care Med.
153:1888–1896. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Balkom RH, van der Heijden HF, van
Herwaarden CL and Dekhuijzen PN: Corticosteroid-induced myopathy of
the respiratory muscles. Neth J Med. 45:114–122. 1994.PubMed/NCBI
|
|
23
|
Dekhuijzen PN, Gayan-Ramirez G, de Bock V,
Dom R and Decramer M: Triamcinolone and prednisolone affect
contractile properties and histopathology of rat diaphragm
differently. J Clin Invest. 92:1534–1542. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fletcher LK, Powers SK, Coombes JS, et al:
Glucocorticoid- induced alterations in the rate of diaphragmatic
fatigue. Pharmacol Res. 42:61–68. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van Balkom RH, Dekhuijzen PN, Folgering
HT, Veerkamp JH, Fransen JA and van Herwaarden CL: Effects of
long-term low-dose methylprednisolone on rat diaphragm function and
structure. Muscle Nerve. 20:983–990. 1997.PubMed/NCBI
|
|
26
|
Van Balkom RH, Zhan WZ, Prakash YS,
Dekhuijzen PN and Sieck GC: Corticosteroid effects on isotonic
contractile properties of rat diaphragm muscle. J Appl Physiol.
83:1062–1067. 1997.PubMed/NCBI
|
|
27
|
Dekhuijzen PN, Gayan-Ramirez G, Bisschop
A, et al: Rat diaphragm contractility and histopathology are
affected differently by low dose treatment with methylprednisolone
and deflazacort. Eur Respir J. 8:824–830. 1995.PubMed/NCBI
|
|
28
|
Sieck GC, van Balkom RH, Prakash YS, Zhan
WZ and Dekhuijzen PN: Corticosteroid effects on diaphragm
neuromuscular junctions. J Appl Physiol. 86:114–122.
1999.PubMed/NCBI
|
|
29
|
Sieck GC and Prakash YS: Morphological
adaptations of neuromuscular junctions depend on fiber type. Can J
Appl Physiol. 22:197–230. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Prakash YS, Miller SM, Huang M and Sieck
GC: Morphology of diaphragm neuromuscular junctions on different
fibre types. J Neurocytol. 25:88–100. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hemmerling TM and Donati F: Neuromuscular
blockade at the larynx, the diaphragm and the corrugator supercilii
muscle: a review. Can J Anaesth. 50:779–794. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hemmerling TM, Schmidt J, Hanusa C, Wolf T
and Schmitt H: Simultaneous determination of neuromuscular block at
the larynx, diaphragm, adductor pollicis, orbicularis oculi and
corrugator supercilii muscles. Br J Anaesth. 85:856–860. 2000.
View Article : Google Scholar
|
|
33
|
Cantineau JP, Porte F, d’Honneur G and
Duvaldestin P: Neuromuscular effects of rocuronium on the diaphragm
and adductor pollicis muscles in anesthetized patients.
Anesthesiology. 81:585–590. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Donati F, Meistelman C and Plaud B:
Vecuronium neuromuscular blockade at the diaphragm, the orbicularis
oculi, and adductor pollicis muscles. Anesthesiology. 73:870–875.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pansard JL, Chauvin M, Lebrault C, Gauneau
P and Duvaldestin P: Effect of an intubating dose of
succinylcholine and atracurium on the diaphragm and the adductor
pollicis muscle in humans. Anesthesiology. 67:326–330. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Donati F, Meistelman C and Plaud B:
Vecuronium neuromuscular blockade at the adductor muscles of the
larynx and adductor pollicis. Anesthesiology. 74:833–837. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Day NS, Blake GJ, Standaert FG and
Dretchen KL: Characterization of the train-of-four response in fast
and slow muscles: effect of d-tubocurarine, pancuronium, and
vecuronium. Anesthesiology. 58:414–417. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma K, Mallidis C, Bhasin S, et al:
Glucocorticoid-induced skeletal muscle atrophy is associated with
upregulation of myostatin gene expression. Am J Physiol Endocrinol
Metab. 285:E363–E371. 2003.PubMed/NCBI
|
|
39
|
Burke RE, Levine DN, Tsairis P and Zajac
FE III: Physiological types and histochemical profiles in motor
units of the cat gastrocnemius. J Physiol. 234:723–748. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brooke MH and Kaiser KK: Three ‘myosin
adenosine triphosphatase’ systems: the nature of their pH lability
and sulfhydryl dependence. J Histochem Cytochem. 18:670–672.
1970.
|
|
41
|
Peter JB, Barnard RJ, Edgerton VR,
Gillespie CA and Stempel KE: Metabolic profiles of three fiber
types of skeletal muscle in guinea pigs and rabbits. Biochemistry.
11:2627–2633. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sieck GC, Lewis MI and Blanco CE: Effects
of undernutrition on diaphragm fiber size, SDH activity, and
fatigue resistance. J Appl Physiol. 66:2196–2205. 1989.PubMed/NCBI
|
|
43
|
Lewis MI, Sieck GC, Fournier M and Belman
MJ: Effect of nutritional deprivation on diaphragm contractility
and muscle fiber size. J Appl Physiol. 60:596–603. 1986.PubMed/NCBI
|
|
44
|
Koerts-De Lang E, Schols AM, Wouters EF,
Gayan-Ramirez G and Decramer M: Contractile properties and
histochemical characteristics of the rat diaphragm after prolonged
triamcinolone treatment and nutritional deprivation. J Muscle Res
Cell Motil. 19:549–555. 1998.
|
|
45
|
Dekhuijzen PN, Gayan-Ramirez G, Bisschop
A, De Bock V, Dom R and Decramer M: Corticosteroid treatment and
nutritional deprivation cause a different pattern of atrophy in rat
diaphragm. J Appl Physiol. 78:629–637. 1995.PubMed/NCBI
|
|
46
|
Lewis MI and Sieck GC: Effect of acute
nutritional deprivation on diaphragm structure and function in
adolescent rats. J Appl Physiol. 73:974–978. 1992.PubMed/NCBI
|
|
47
|
Van Wilgenburg H: The effect of
prednisolone on neuromuscular transmission in the rat diaphragm.
Eur J Pharmacol. 55:355–361. 1979.
|
|
48
|
Wilson RW, Ward MD and Johns TR:
Corticosteroids: a direct effect at the neuromuscular junction.
Neurology. 24:1091–1095. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kotsarini C, Griffiths PD, Wilkinson ID
and Hoggard N: A systematic review of the literature on the effects
of dexamethasone on the brain from in vivo human-based studies:
implications for physiological brain imaging of patients with
intracranial tumors. Neurosurgery. 67:1799–1815. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kularatne SA, Walathara C, Mahindawansa
SI, et al: Efficacy of low dose dexamethasone in severe
thrombocytopenia caused by dengue fever: a placebo controlled
study. Postgrad Med J. 85:525–529. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hardy JR, Rees E, Ling J, et al: A
prospective survey of the use of dexamethasone on a palliative care
unit. Palliat Med. 15:3–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Leeuwin RS and Wolters EC: Effect of
corticosteroids on sciatic nerve-tibialis anterior muscle of rats
treated with hemicholinium-3. An experimental approach to a
possible mechanism of action of corticosteroids in myasthenia
gravis. Neurology. 27:171–177. 1977. View Article : Google Scholar
|
|
53
|
Arts WF and Oosterhuis HJ: Long-term
effect of glucocorticosteroids on neuromuscular blocking in mice. J
Neurol Neurosurg Psychiatry. 40:675–677. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wolters MJ and Leeuwin RS: Effect of
corticosteroids on the phrenic nerve-diaphragm of preparation
treated with hemicholinium. A possible model of myasthenia gravis.
Neurology. 26:574–578. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tomlinson ES, Maggs JL, Park BK and Back
DJ: Dexamethasone metabolism in vitro: species differences. J
Steroid Biochem Mol Biol. 62:345–352. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Crossland H, Constantin-Teodosiu D,
Greenhaff PL and Gardiner SM: Low-dose dexamethasone prevents
endotoxaemia-induced muscle protein loss and impairment of
carbohydrate oxidation in rat skeletal muscle. J Physiol.
588:1333–1347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kitano M, Ishinaga H, Shimizu T, Takeuchi
K and Majima Y: Effects of clarithromycin and dexamethasone on
mucus production in isografted rat trachea. Pharmacology. 87:56–62.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Proost JH, Eriksson LI, Mirakhur RK, Roest
G and Wierda JM: Urinary, biliary and faecal excretion of
rocuronium in humans. Br J Anaesth. 85:717–723. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ito S, Nagata O and Ozaki M: Estimated
blood concentration of rocuronium administrated by continuous
infusion to maintain an appropriate neuromuscular blockade under
propofol anesthesia. Masui. 59:82–86. 2010.(In Japanese).
|
|
60
|
Dragne A, Varin F, Plaud B and Donati F:
Rocuronium pharmacokinetic-pharmacodynamic relationship under
stable propofol or isoflurane anesthesia. Can J Anaesth.
49:353–360. 2002. View Article : Google Scholar
|
|
61
|
Braunstein PW Jr and DeGirolami U:
Experimental corticosteroid myopathy. Acta Neuropathol. 55:167–172.
1981. View Article : Google Scholar
|
